Medpal AI PLC
MPAL · AIM · Health Care · mcap £54m · 6.1p
| Date | Type | Announcement | Day |
|---|---|---|---|
| 09 Oct 26 | Circular and Notice of General Meeting
Further to its announcement of 6 October 2026, MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-native digital health and pharmacy group, announces that a shareholder circular convening a General Meeting has been posted on th |
+1.7% | |
| 08 Oct 26 | Trading update | Trading Update
Record daily prescription orders of 2,300 on 5 October; £8m working capital facility indicative term sheet received; £6.4m cash position. |
+3.8% |
| 06 Oct 26 | September Update and Circular to Shareholders
September revenue reached £3.2m annualised run rate £38m, repeat orders now £1m monthly, GLP-1 expansion on track. |
−13.4% | |
| 21 Sep 26 | Trading update | Issue of Equity and Trading Update | |
| 11 Sep 26 | Exercise of Warrants
MedPal AI plc (AIM: MPAL; FRA: Z1N), the AI-powered, integrated digital health and pharmacy company, announces that the Company has received a notice to exercise warrants over a total of 4,130,833 new ordinary shares of |
−3.8% | |
| 09 Sep 26 | Board change | Board Change and Issue of Options
Harvey Sinclair appointed as independent Non-executive Director; 40m options granted to CEO Jason Drummond. |
−5.4% |
| 07 Sep 26 | Trading update | August Trading Update
New Health revenue reached £1.8m in August, first full month; Group annualised run rate now approximately £28m. |
+15.4% |
| 04 Sep 26 | Completion of eMARx Acquisition-Issue of Equity
Final Consideration for eMARx, Issue of Equity and Total Voting Rights |
−5.5% | |
| 01 Sep 26 | FDA Approval of Mounjaro for Heart Protection
FDA approves Mounjaro for cardiovascular protection in type 2 diabetes, expanding GLP-1 market beyond weight loss. |
+1.1% | |
| 11 Aug 26 | UK Authorises Eli Lilly's Once Daily GLP-1 Pill
UK becomes first European country to authorise Eli Lilly's once-daily oral GLP-1 tablet orforglipron for weight loss. |
+3.2% | |
| 04 Aug 26 | Trading update | July Trading Update
Annualised revenue run rate reached £8.6m across three revenue streams, up 70% in two months. |
+11.3% |
| 03 Aug 26 | Routine | Total Voting Rights | |
| 20 Jul 26 | Acquisition of eMARx
MedPal acquires eMARx, a UK care home medication administration software provider, completing its Health OS platform. |
+2.9% | |
| 03 Jul 26 | Fundraise | Placing to raise £5m
Medpal AI raises £5m via placing at 3.5p per share to fund Solid State Technologies acquisition and oral Wegovy launch. |
−8.7% |
| 01 Jul 26 | Approval of New Dispensing Facility
Opened Sarus Court, a 23,000 sq ft robotic pharmacy dispensing facility in Runcorn with NHS approval. |
+5.0% | |
| 18 Jun 26 | Launch of Juno, MedPal's AI Health Companion
MedPal AI launches Juno, an agentic AI health companion powered by Anthropic's Claude models and DigitalOcean infrastructure. |
+1.3% | |
| 12 Jun 26 | Approval of First Oral GLP-1 for Weight Loss in UK
MHRA approves first oral GLP-1 for weight loss in UK, creating opportunity for MedPal's New Health clinic. |
+33.9% | |
| 10 Jun 26 | Launch of new.co.uk Marketing Campaign
MedPal AI launched paid digital marketing campaign for new.co.uk weight management clinic ahead of anticipated UK oral GLP-1 approval. |
−6.5% | |
| 01 Jun 26 | Pharmacy Operational Update
Record monthly dispensing volume of 42,250 items in May 2026; cumulative total exceeds 250,000 items since launch. |
+10.0% | |
| 29 May 26 | Results | Half-year Results
MedPal AI reports first revenues of £1.6m from pharmacy operations five months after AIM admission; planning Q4 2026 breakeven. |
+2.0% |
| 20 May 26 | Launch of New Health dedicated GLP/peptides brand
MedPal AI launches New Health, a dedicated GLP-1 and peptides consumer brand, with £1.3 million marketing investment. |
+4.2% | |
| 01 May 26 | Routine | Change of Registered Office | |
| 30 Apr 26 | Routine | Total Voting Rights-replacement | |
| 30 Apr 26 | Routine | Total Voting Rights | |
| 29 Apr 26 | Acquisition of Remedi Pharmacy Assets
MedPal AI acquires Remedi pharmacy assets in Runcorn for £310,000 cash, targeting pharmacy EBITDA breakeven at 80,000 items per month. |
+0.8% | |
| 22 Apr 26 | Holding | Holding(s) in Company | |
| 22 Apr 26 | Holding | Holding(s) in Company | |
| 20 Apr 26 | Issue of Fee Shares
3.6m ordinary shares issued at 2.5p per share in lieu of £90,000 advisory fees. |
−12.4% | |
| 17 Apr 26 | Fundraise | Placing to raise £3m
MedPal AI raises £3m through placing of 120m shares at 2.5p per share to fund growth towards profitability. |
−8.7% |
| 08 Apr 26 | Updated Research Note
Optimo Research updates coverage; CEO interview highlights 200,000 prescription orders processed since launch. |
+12.0% | |
| 08 Apr 26 | Launch of MedPal Health OS
MedPal AI launches integrated Health OS combining wearables, AI triage, clinician prescribing and robotic dispensing. |
+12.0% | |
| 07 Apr 26 | Pharmacy Operational Update
Record pharmacy dispensing of 41,600 items in March 2026, annualised revenue exceeding £5m with 34% gross margin. |
+31.6% | |
| 02 Apr 26 | Routine | Result of AGM - Replacement | |
| 02 Apr 26 | Holding | Holding(s) in Company | |
| 02 Apr 26 | Holding | Holding(s) in Company | |
| 31 Mar 26 | Routine | Total Voting Rights | |
| 30 Mar 26 | Routine | Result of AGM | |
| 25 Mar 26 | Fundraise | Result of WRAP Retail Offer
Company completes fundraise of £932,160 through placing, subscription and retail offer at 2.5p per share. |
−2.3% |
| 20 Mar 26 | Fundraise | WRAP Retail Offer
MedPal AI raising up to £727,000 through retail offer and placing at 2.5p per share. |
+0.9% |
| 20 Mar 26 | Fundraise | Placing and WRAP Retail Offer
MedPal AI raises £527,000 through placing of 21.08m shares at 2.5p, with retail offer to follow. |
+0.9% |
| 20 Mar 26 | MedPal Enters At-Home Blood Testing Market
MedPal launches at-home blood testing service for GLP-1 medication users, starting with weight loss test. |
+0.9% | |
| 16 Mar 26 | Pharmacy Operational Update
MedPal pharmacy dispensed 147,000 items in first four months generating £1.5m turnover with 33% gross margin. |
+8.7% | |
| 09 Mar 26 | Routine | Notice of AGM and Board Changes | |
| 27 Feb 26 | Results | Final Results
Pre-revenue AIM admission in August 2025 followed by rapid operational build-out generating over £350,000 monthly pharmacy revenue by January 2026. |
−7.9% |
| 27 Feb 26 | Routine | Total Voting Rights | |
| 25 Feb 26 | Update and close of ATM
Company raised £303,355.50 through ATM facility, closing it after total proceeds of £1,993,100. |
−2.4% | |
| 16 Feb 26 | Completion of Acquisition
Medpal AI completed acquisition of Universal Pharmacy assets and tripled Swaffham robotic distribution facility capacity. |
−7.1% | |
| 12 Feb 26 | Result of ATM - replacement
Raised £467,640 via ATM facility through issue of 9 million shares at 5.20p per share. |
−0.9% | |
| 11 Feb 26 | Update on ATM Facility
Company raised £467,640 via ATM facility through issue of 9 million shares at 5.20p. |
−1.9% | |
| 10 Feb 26 | Vertically Integrated Healthcare Model
MedPal AI operational update on vertically integrated UK healthcare platform with multi-channel revenue model and January 2026 performance metrics. |
+2.9% | |
| 05 Feb 26 | Pharmacy operations update
Pharmacy operations dispensed 36,951 items in January 2026, up 10.5% month-on-month. |
+4.9% | |
| 03 Feb 26 | Secondary Listing on Frankfurt Exchange
MedPal AI's ordinary shares admitted to trading on Frankfurt Stock Exchange Open Market under ticker Z1N. |
+4.7% | |
| 30 Jan 26 | Routine | Total Voting Rights | |
| 28 Jan 26 | Eli Lilly Supply Agreement
MedPal AI approved as authorised purchaser of Eli Lilly pharmaceutical products including Mounjaro in UK. |
+7.1% | |
| 26 Jan 26 | Result of ATM
Company raised £339,560 via ATM facility through issue of 6.5m shares at 5.22p |
+0.0% | |
| 22 Jan 26 | Operational Efficiency Gains in Pharmacy
MedPal subsidiary achieved 30-fold increase in dispensing efficiency through server infrastructure upgrades. |
+0.0% | |
| 16 Jan 26 | Update on ATM Facility
MedPal AI raised £378,870 via ATM facility, issuing 6.2m shares at 6.11p average price. |
+0.0% | |
| 08 Jan 26 | AI Integration with MedPal Clinic
MedPal app now uses AI to identify users eligible for weight management treatments and integrate them with MedPal Clinic pharmacy. |
+3.9% | |
| 05 Jan 26 | Trading update | Trading Update
December pharmacy operations processed 33,433 prescriptions generating £325,000 turnover, up 16% month-on-month. FDA approved oral GLP-1. |
+35.0% |
| 16 Dec 25 | Update on ATM Facility
Raised £498,225 via ATM facility through issue of 7.5m shares at 6.643p average price. |
−5.6% | |
| 09 Dec 25 | Board change | CEO Interview on Vox Markets
CEO interview published on Vox Markets discussing app upgrade and Epassi partnership. |
−5.2% |
| 08 Dec 25 | App Update and Rollout to Epassi UK Gym Network
Major app update released with AI capabilities, rolled out to 11 million+ users via Epassi UK gym network partnership. |
+0.0% | |
| 04 Dec 25 | Trading update | Trading Update and At The Market Facility
MedPal processed 28,789 pharmacy orders in November with 90% month-on-month growth; deployed Google Vertex AI on WhatsApp; established £2m ATM facility. |
+16.0% |
| 10 Nov 25 | NHS Approval & Operational Update
MedPal Limited receives NHS pharmacy contract approval from Norfolk and Waveney ICB; 14,757 prescriptions dispensed since October acquisition. |
+13.8% | |
| 07 Nov 25 | Launch of MedPal Clinic Pharmacy Platform
MedPal AI launches MedPal.clinic, an AI-powered pharmacy platform offering free consultations and same-day delivery. |
+7.4% | |
| 03 Nov 25 | Initiation of research
Optimo Research has initiated coverage of MedPal AI plc. |
+2.9% | |
| 22 Oct 25 | Opening of AI-powered National Distribution Centre
Opened AI-powered 24/7 national distribution centre for pharmacy services with robotic dispensing and same-day delivery capability. |
+2.9% |
Company filings. Not investment advice.